Press Release: ReposiTrak, Inc. Declares its Third 10% Increase in its Quarterly Cash Dividend

Dow Jones
2025/06/05

Dividend Growth Reflects Ongoing Commitment to Shareholders

SALT LAKE CITY--(BUSINESS WIRE)--June 05, 2025-- 

ReposiTrak, Inc. (NYSE: TRAK), the world's largest food traceability and regulatory compliance network, built upon its proven inventory management and out-of-stock reduction SaaS platform, today announced its third 10% increase in its quarterly cash dividend in the prior three years. The new dividend of $0.02 per share per quarter (equivalent to $0.08 per share annually) will be paid to shareholders of record as of September 30, 2025, on or about November 14, 2025. Subsequent dividends will be paid within 45 days of each fiscal quarter end.

Randall K. Fields, Chairman and CEO of ReposiTrak commented, "This marks the third time that ReposiTrak has increased its quarterly dividend in the past three years reflecting our financial performance and ongoing commitment to returning more and more capital to our shareholders. Our capital allocation plan is a balanced objective: as we have said, and more importantly delivered for now three consecutive years, our goal is to return 50% of our annual operating cash flow to shareholders through dividends, paying off debt, and share repurchases, while the other 50% will be reserved and allocated to invest in growth while simultaneously maintaining a robust balance sheet. The Board's decision to raise the dividend again is a testament to its confidence in the strength of our business model and the opportunities ahead."

About ReposiTrak:

ReposiTrak (NYSE: TRAK) provides retailers, suppliers, food manufacturers and wholesalers with a robust solution suite to help reduce risk and remain in compliance with regulatory requirements, enhance operational controls and increase sales with unrivaled brand protection. Consisting of three product families -- food traceability, compliance and risk management and supply chain solutions -- ReposiTrak' s integrated, cloud-based applications are supported by an unparalleled team of experts. For more information, please visit https://repositrak.com.

Forward-Looking Statements:

Any statements contained in this press release that are not historical facts are forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Words such as "anticipate," "believe," "estimate," "expect," "forecast," "intend," "may," "plan," "project," "predict," "if", "should" and "will" and similar expressions as they relate to ReposiTrak Inc. are intended to identify such forward-looking statements. ReposiTrak may from time-to-time update these publicly announced projections, but it is not obligated to do so. Any projections of future results of operations should not be construed in any manner as a guarantee that such results will in fact occur. These projections are subject to change and could differ materially from final reported results. For a discussion of such risks and uncertainties, see "Risk Factors" in our annual report on Form 10-K, our quarterly report on Form 10-Q, and our other reports filed with the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the dates on which they are made.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250605930658/en/

 
    CONTACT:    Investor Relations: 

John Merrill, CFO

investor-relations@repositrak.com

or

FNK IR

Rob Fink

646-809-4048

rob@fnkir.com

 
 

(END) Dow Jones Newswires

June 05, 2025 08:00 ET (12:00 GMT)

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10